SCHEMBL6154747

SCHEMBL6154747

Oc1cccc(Oc2c[c]ccc2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.42
LMNA P02545 2/20 0.39
CA12 O43570 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CA2 P00918 1/20 0.39
CA5A P35218 1/20 0.39
CA9 Q16790 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CA14 Q9ULX7 1/20 0.39
CA5B Q9Y2D0 1/20 0.39
APP P05067 1/20 0.38
CHRNB2 P17787 1/20 0.38
CHRNA4 P43681 1/20 0.38
LTA4H P09960 1/20 0.36
NR1H2 P55055 1/20 0.36
BAX Q07812 1/20 0.36
RAB9A P51151 1/20 0.36
CHRNB4 P30926 2/20 0.36
CHRNA3 P32297 2/20 0.36
KDR P35968 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30358272 0.82 CYP3A4 (0.58) CYP3A4LMNACA12ALDH1A1CA2
SCHEMBL8155454 0.82 LTA4H (0.43) ALDH1A1CA2LTA4HNR1H2BAX
SCHEMBL813557 0.82 CYP3A4 (0.58) CYP3A4LMNACA12ALDH1A1CA2
SCHEMBL6154322 0.81 LTA4H (0.59) LMNAALDH1A1CA2LTA4HNR1H2
SCHEMBL2881029 0.81 CYP3A4 (0.44) CYP3A4LMNACA12ALDH1A1CA2
SCHEMBL9261806 0.81 MAOB (0.48) ALDH1A1HSD17B10LTA4HNR1H2BAX
SCHEMBL3182473 0.80 CYP3A4 (0.55) CYP3A4LMNACA12ALDH1A1CA2
SCHEMBL29719326 0.80 CYP3A4 (0.55) CYP3A4LMNACA12ALDH1A1CA2
SCHEMBL5143789 0.80 CYP3A4 (0.55) CYP3A4LMNACA12ALDH1A1CA2
SCHEMBL919378 0.78 ALDH1A1 (0.53) LMNAALDH1A1MAPTHTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP CYP3A4 4650/4885LMNA 4884/4885CA12 4547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.